{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T07:56:08Z","timestamp":1791618968218,"version":"4.3.4"},"reference-count":53,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T00:00:00Z","timestamp":1661731200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>Introduction: Eosinophilic esophagitis (EoE) is now recognized as the main inflammatory condition that leads to fibrosis, unlike other chronic inflammatory gastrointestinal diseases, such as celiac disease. The aim of our study is to characterize the collagen deposition and cytokine expression involved in the fibrogenic response in patients affected by EoE in comparison to celiac disease. Materials and Methods: Consecutive patients with a clinical suspicion of untreated EoE or active celiac disease were enrolled. In the control group, patients with negative upper endoscopy were included. Total RNA was isolated from biopsy specimens using a commercial kit (SV Total RNA Isolation System, Promega Italia Srl). Quantitative real-time PCR (qRT-PCR) was performed in triplicate using a StepOne\u2122 Real-Time PCR instrument (Thermo Fisher Scientific, Monza, Italy). mRNA encoding for inflammatory molecules: interleukin 4 (IL-4), interleukin 5 (IL-5), interleukin 13 (IL-13), and fibrotic markers: transforming growth factor beta 1 (TGF-\u03b2), mitogen-activated protein kinase kinase kinase 7 (MAP3K7), serpin family E member 1 (SERPINE1), were quantified using TaqMan Gene Expression Assays (Applied Biosystems). RESULTS. In EoE, the qPCR analysis showed an increase in all the inflammatory cytokines. Both IL-5 and Il-3 mRNA expression resulted in a statistically significant increase in oesophageal mucosa with respect to the celiac duodenum, while no differences were present in IL-4 expression. TGF-\u03b2 expression was similar to the controls in the mid esophagus but reduced in the distal EoE esophagus (RQ: 0.46 \u00b1 0.1). MAP3K7 expression was reduced in the mid esophagus (RQ: 0.59 \u00b1 0.3) and increased in the distal esophagus (RQ: 1.75 \u00b1 0.6). In turn, the expression of SERPINE1 was increased in both segments and was higher in the mid than in the distal esophagus (RQ: 5.25 \u00b1 3.9, 1.92 \u00b1 0.9, respectively). Collagen deposition was greater in the distal esophagus compared to the mid esophagus [18.1% \u00b1 8 vs. 1.3% \u00b1 1; p = 0.008]. Conclusions: The present study confirms the esophageal fibrotic involution involving the distal esophagus and shows that the inflammatory pathway in EoE is peculiar to this disease and different from other chronic inflammatory gastrointestinal disorders such as celiac disease.<\/jats:p>","DOI":"10.3390\/diagnostics12092092","type":"journal-article","created":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T21:01:31Z","timestamp":1661806891000},"page":"2092","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Eosinophilic Esophagitis: Cytokines Expression and Fibrotic Markers in Comparison to Celiac Disease"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6356-8902","authenticated-orcid":false,"given":"Annamaria","family":"Pronio","sequence":"first","affiliation":[{"name":"Department of General Surgery and Surgical Specialties \u2018Paride Stefanini\u2019, Sapienza University of Rome, 00185 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Covotta","sequence":"additional","affiliation":[{"name":"Department of General Surgery and Surgical Specialties \u2018Paride Stefanini\u2019, Sapienza University of Rome, 00185 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Pallotta","sequence":"additional","affiliation":[{"name":"Department of Translational and Precision Medicine, Sapienza University of Rome, 00185 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossella","family":"Palma","sequence":"additional","affiliation":[{"name":"Department of General Surgery and Surgical Specialties \u2018Paride Stefanini\u2019, Sapienza University of Rome, 00185 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danilo","family":"Badiali","sequence":"additional","affiliation":[{"name":"Department of Translational and Precision Medicine, Sapienza University of Rome, 00185 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Carlotta","family":"Sacchi","sequence":"additional","affiliation":[{"name":"Department of Translational and Precision Medicine, Sapienza University of Rome, 00185 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonietta","family":"Lamazza","sequence":"additional","affiliation":[{"name":"Department of Surgery Pietro Valdoni, Sapienza University of Rome, 00185 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9249-1318","authenticated-orcid":false,"given":"Carola","family":"Severi","sequence":"additional","affiliation":[{"name":"Department of Translational and Precision Medicine, Sapienza University of Rome, 00185 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,8,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jaci.2011.02.040","article-title":"Eosinophilic esophagitis: Updated consensus recommendations for children and adults","volume":"128","author":"Liacouras","year":"2011","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1056\/NEJMra1502863","article-title":"Eosinophilic Esophagitis","volume":"373","author":"Furuta","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/00042737-200602000-00015","article-title":"Eosinophilic esophagitis in adults: A systematic review","volume":"18","author":"Sgouros","year":"2006","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1442-2050.2007.00721.x","article-title":"Patient characteristics, clinical, endoscopic, and histologic findings in adult eosinophilic esophagitis: A case series and systematic review of the medical literature","volume":"20","author":"Pasha","year":"2007","journal-title":"Dis. Esophagus"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1111\/j.1572-0241.2007.01512.x","article-title":"Prevalence and Predictive Factors of Eosinophilic Esophagitis in Patients Presenting with Dysphagia: A Prospective Study","volume":"102","author":"Prasad","year":"2007","journal-title":"Am. J. Gastroenterol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.dld.2010.08.002","article-title":"Prevalence of eosinophilic esophagitis in patients with refractory gastroesophageal reflux disease symptoms: A prospective study","volume":"43","author":"Quintana","year":"2011","journal-title":"Dig. Liver Dis."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1111\/j.1365-2036.2008.03795.x","article-title":"Eosinophilic oesophagitis in patients presenting with dysphagia\u2014A prospective analysis","volume":"28","author":"Mackenzie","year":"2008","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1053\/j.gastro.2014.01.051","article-title":"T-Helper 2 Cytokines, Transforming Growth Factor \u03b21, and Eosinophil Products Induce Fibrogenesis and Alter Muscle Motility in Patients with Eosinophilic Esophagitis","volume":"146","author":"Rieder","year":"2014","journal-title":"Gastroenterology"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"4033","DOI":"10.4049\/jimmunol.0903069","article-title":"Coordinate Interaction between IL-13 and Epithelial Differentiation Cluster Genes in Eosinophilic Esophagitis","volume":"184","author":"Blanchard","year":"2010","journal-title":"J. Immunol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"660","DOI":"10.4049\/jimmunol.1000471","article-title":"IL-13 induces esophageal remodeling and gene expression by an eosino-phil-independent, IL-13R alpha 2-inhibited pathway","volume":"185","author":"Zuo","year":"2010","journal-title":"J. Immunol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1053\/j.gastro.2010.03.057","article-title":"Interleukin-15 Expression Is Increased in Human Eosinophilic Esophagitis and Mediates Pathogenesis in Mice","volume":"139","author":"Zhu","year":"2010","journal-title":"Gastroenterology"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1365-2036.2006.02984.x","article-title":"Review article: The pathogenesis and management of eosinophilic oesophagitis","volume":"24","author":"Furuta","year":"2006","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.cyto.2015.05.010","article-title":"T helper 2 (Th2) cell differentiation, type 2 innate lymphoid cell (ILC2) development and regulation of interleukin-4 (IL-4) and IL-13 production","volume":"75","author":"Zhu","year":"2015","journal-title":"Cytokine"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1053\/j.gastro.2007.10.002","article-title":"Esophageal Remodeling Develops as a Consequence of Tissue Specific IL-5-Induced Eosinophilia","volume":"134","author":"Mishra","year":"2008","journal-title":"Gastroenterology"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1053\/j.gastro.2017.06.065","article-title":"Pathophysiology of Eosinophilic Esophagitis","volume":"154","author":"Aceves","year":"2018","journal-title":"Gastroenterology"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1093\/intimm\/dxn060","article-title":"IL- amplifies both Th1- and Th2-type responses through its activity on human basophils, allergen- reactive Th2 cells, iNKT and NK cells","volume":"20","author":"Smithgall","year":"2008","journal-title":"Int. Immunol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1097\/01.bor.0000139310.77347.9c","article-title":"Cellular origins of fibroblasts: Possible implications for organ fibrosis in systemic sclerosis","volume":"16","author":"Postlethwaite","year":"2010","journal-title":"Curr. Opin. Rheumatol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2353\/ajpath.2010.090517","article-title":"Fate Tracing Reveals the Pericyte and Not Epithelial Origin of Myofibroblasts in Kidney Fibrosis","volume":"176","author":"Humphreys","year":"2010","journal-title":"Am. J. Pathol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3389\/fphar.2014.00123","article-title":"Fibroblasts in fibrosis: Novel roles and mediators","volume":"5","author":"Kendall","year":"2014","journal-title":"Front. Pharmacol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/path.2277","article-title":"Cellular and molecular mechanisms of fibrosis","volume":"214","author":"Wynn","year":"2008","journal-title":"J. Pathol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"159","DOI":"10.7326\/0003-4819-152-3-201002020-00007","article-title":"Narrative Review: Fibrotic Diseases: Cellular and Molecular Mechanisms and Novel Therapies","volume":"152","author":"Rosenbloom","year":"2010","journal-title":"Ann. Intern. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1056\/NEJMra1300575","article-title":"Fibrosis\u2014A Common Pathway to Organ Injury and Failure","volume":"372","author":"Rockey","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_23","first-page":"1627","article-title":"Human Fibrotic Diseases: Current Challenges in Fibrosis Research. Fibrosis: Methods and Protocols","volume":"2017","author":"Rosenbloom","year":"2017","journal-title":"Methods Mol. Biol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/cr.2008.326","article-title":"TGF-beta signaling in vascular biology and dysfunction","volume":"19","author":"Goumans","year":"2009","journal-title":"Cell Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1042\/BJ20101500","article-title":"Transforming growth factor-beta2 promotes Snail-mediated endothelial-mesenchymal transition through convergence of Smad-dependent and Smad-independent signalling","volume":"437","author":"Medici","year":"2011","journal-title":"Biochem. J."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s00441-011-1222-6","article-title":"Regulation of endothelial cell plasticity by TGF-beta","volume":"347","year":"2012","journal-title":"Cell Tissue Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1096\/fj.03-1273rev","article-title":"TGF-beta signaling and the fibrotic response","volume":"18","author":"Leask","year":"2004","journal-title":"FASEB J."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/jcp.22783","article-title":"PAI-1 in tissue fibrosis","volume":"227","author":"Ghosh","year":"2012","journal-title":"J. Cell. Physiol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1177\/2050640619844125","article-title":"European Society for the Study of Coeliac Disease (ESsCD) guideline for coeliac disease and other gluten-related disorders","volume":"7","author":"Volta","year":"2019","journal-title":"United Eur. Gastroenterol. J."},{"key":"ref_30","first-page":"G284","article-title":"Protective role of angiotensin II type 2 receptor signaling in a mouse model of pancreatic fibrosis","volume":"296","author":"Ulmasov","year":"2009","journal-title":"Am. J. Physiol. Liver Physiol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1056\/NEJM200408263510924","article-title":"Eosinophilic esophagitis","volume":"351","author":"Noel","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.jaci.2004.11.006","article-title":"Eosinophilic esophagitis: Escalating epidemiology?","volume":"115","author":"Straumann","year":"2005","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/MPG.0b013e318239be75","article-title":"A Decade of Hospital Discharges Related to Eosinophilic Esophagitis","volume":"54","author":"Erwin","year":"2012","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/MPG.0b013e318291fee2","article-title":"Incidence and Prevalence of Eosinophilic Esophagitis in Children","volume":"57","author":"Soon","year":"2013","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1111\/apt.15231","article-title":"Systematic review with meta-analysis: The growing incidence and prevalence of eosinophilic oesophagitis in children and adults in population-based studies","volume":"49","author":"Navarro","year":"2019","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1056\/NEJM199805283382206","article-title":"Eosinophilia","volume":"338","author":"Rothenberg","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1016\/j.jaci.2012.03.005","article-title":"Eosinophilic esophagitis: Epithelial mesenchymal transition contributes to esophageal remodeling and reverses with treatment","volume":"129","author":"Kagalwalla","year":"2012","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1136\/gut.2009.178558","article-title":"Anti-interleukin5 antibody treatment (mepolizumab) in active eosinophilic oe-sophagitis: A randomised, placebo-controlled, double-blind trial","volume":"59","author":"Straumann","year":"2010","journal-title":"Gut"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1053\/j.gastro.2011.07.044","article-title":"An Antibody Against IL-5 Reduces Numbers of Esophageal Intraepithelial Eosinophils in Children with Eosinophilic Esophagitis","volume":"141","author":"Gupta","year":"2011","journal-title":"Gastroenterology"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/j.jaci.2013.02.042","article-title":"Anti\u2013IL-5 therapy reduces mast cell and IL-9 cell numbers in pediatric patients with eosinophilic esophagitis","volume":"131","author":"Otani","year":"2013","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jaci.2011.11.044","article-title":"Reslizumab in children and adolescents with eosinophilic esophagitis: Results of a double-blind, randomized, placebo-controlled trial","volume":"129","author":"Spergel","year":"2012","journal-title":"Allergy Clin. Immunol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jaci.2003.10.047","article-title":"Eosinophilic gastrointestinal disorders (EGID)","volume":"113","author":"Rothenberg","year":"2004","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1053\/j.gastro.2018.10.051","article-title":"RPC4046, a Monoclonal Antibody Against IL13, Reduces Histologic and Endoscopic Activity in Patients with Eosinophilic Esophagitis","volume":"156","author":"Hirano","year":"2019","journal-title":"Gastroenterology"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1615\/CritRevImmunol.v37.i2-6.30","article-title":"Functions of IL-4 and Control of Its Expression","volume":"37","author":"Brown","year":"2017","journal-title":"Crit Rev. Immunol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1053\/j.gastro.2016.09.047","article-title":"Mechanisms, Management, and Treatment of Fibrosis in Patients with Inflammatory Bowel Diseases","volume":"152","author":"Rieder","year":"2017","journal-title":"Gastroenterology"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.gie.2017.12.020","article-title":"Obtaining adequate lamina propria for subepithelial fibrosis evaluation in pediatric eosinophilic esophagitis","volume":"87","author":"Wang","year":"2018","journal-title":"Gastrointest. Endosc."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.jaci.2016.02.028","article-title":"TGF-\u03b21\u2013induced PAI-1 contributes to a profibrotic network in patients with eosinophilic esophagitis","volume":"138","author":"Rawson","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3109\/08977194.2011.595714","article-title":"Frangogiannis NG.TGF-\u03b2 signaling in fibrosis","volume":"29","author":"Biernacka","year":"2011","journal-title":"Growth Factors"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S1074-7613(00)80170-3","article-title":"Abrogation of TGF beta signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease","volume":"12","author":"Gorelik","year":"2000","journal-title":"Immunity"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"12215","DOI":"10.1073\/pnas.92.26.12215","article-title":"Early-onset multifocal inflammation in the transforming growth factor beta 1-null mouse is lymphocyte mediated","volume":"92","author":"Diebold","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S0006-291X(03)01207-5","article-title":"A dominant negative TAK1 inhibits cellular fibrotic responses induced by TGF-\u03b2","volume":"307","author":"Ono","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"25920","DOI":"10.1074\/jbc.M501150200","article-title":"Disabled-2 (Dab2) Mediates Transforming Growth Factor \u03b2(TGF\u03b2)-stimulated Fibronectin Synthesis through TGF\u03b2-activated Kinase 1 and Activation of the JNK Pathway","volume":"280","author":"Hocevar","year":"2005","journal-title":"J. Biol Chem."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/18465","article-title":"The kinase TAK1 can activate the NIK-I kappaB as well as the MAP kinase cascade in the IL-1 signalling pathway","volume":"398","author":"Kishimoto","year":"1999","journal-title":"Nature"}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/12\/9\/2092\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:19:35Z","timestamp":1760141975000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/12\/9\/2092"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,29]]},"references-count":53,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2022,9]]}},"alternative-id":["diagnostics12092092"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics12092092","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,29]]}}}